Literature DB >> 29435047

GTSF1 gene may serve as a novel potential diagnostic biomarker for liver cancer.

De-Yong Gao1, Yun Ling2, Xiao-Li Lou1, Ying-Ying Wang1, Liang-Ming Liu1.   

Abstract

The gametocyte-specific factor 1 (GTSF1) gene participates in DNA methylation and retrotransposon activation in germ cells, particularly during cell proliferation. The present study aimed to assess the level of GTSF1 gene expression in liver cancer tumor tissues, and its role in human hepatoma cell lines in vitro and in a nude mouse model in vivo. GTSF1 gene expression was detected in liver cancer tumor tissues, compared with in healthy controls, via reverse transcription quantitative polymerase chain reaction. An adeno-associated virus vector was used to study tumor stem cell proliferation in vivo. A plasmid expressing GTSF1 was constructed and transfected into various human hepatoma cell lines, in order to analyze the cellular proliferation and apoptosis of liver cancer cells using small interfering (si)RNAs in vitro. In the present study, GTSF1 gene expression was detected in 18/24 (75.0%) liver cancer tumor tissues from patients with hepatocellular carcinoma (HCC), and elevated GTSF1 expression was identified in the tissue of one of 32 healthy control samples (3.13%; P<0.05). Notably, the GTSF1 gene was expressed at a higher frequency in AFP-positive HCC samples (14/16, 87.50%) compared with in AFP-negative HCC samples (4/8, 50.0%; P=0.129). In addition, there was no statistical significance between GTSF1 expression in non-HBV-infected (71.42%) and HBV-infected HCC specimens (76.47%), as determined by a χ2 test (P=0.921). It was demonstrated that GTSF1 significantly increased the tumorigenicity of Ad-shNC-transfected (GTSF1-positive) HepG2 cells in the nude mouse xenograft model, whereas the sizes and weights of the tumors in the GTSF1-negative group were dercreased in comparison with the GTSF1-positive group (P<0.05). Reduced levels of GTSF1 mRNA, along with fewer and smaller colonies, were identified in two groups of human liver cancer cells treated with with GTSF1-targeting siRNA, when compared with cells without GTSF1 mRNA interference (P<0.05). In summary, the present study elucidated the GTSF1 mRNA expression pattern in liver cancer, and investigated the potential role of GTSF1 in tumorigenesis. The data suggest an important role for the GTSF1 gene in the molecular etiology of hepatocarcinogenesis, and indicate a potential application of GTSF1 mRNA expression in liver cancer diagnosis and therapy.

Entities:  

Keywords:  diagnostic biomarker; gametocyte specific factor 1 gene; liver cancer

Year:  2017        PMID: 29435047      PMCID: PMC5778804          DOI: 10.3892/ol.2017.7695

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  33 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.

Authors:  Michał Grąt; Oskar Kornasiewicz; Zbigniew Lewandowski; Wacław Hołówko; Karolina Grąt; Konrad Kobryń; Waldemar Patkowski; Krzysztof Zieniewicz; Marek Krawczyk
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

Review 3.  Therapeutic potential of small interfering RNAs/micro interfering RNA in hepatocellular carcinoma.

Authors:  Rossella Farra; Mario Grassi; Gabriele Grassi; Barbara Dapas
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

4.  Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.

Authors:  Meng Li; Hong Zhao; Xiaosong Zhang; Laura D Wood; Robert A Anders; Michael A Choti; Timothy M Pawlik; Hubert D Daniel; Rajesh Kannangai; G Johan A Offerhaus; Victor E Velculescu; Linfang Wang; Shibin Zhou; Bert Vogelstein; Ralph H Hruban; Nick Papadopoulos; Jianqiang Cai; Michael S Torbenson; Kenneth W Kinzler
Journal:  Nat Genet       Date:  2011-08-07       Impact factor: 38.330

Review 5.  Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.

Authors:  Jessica Zucman-Rossi; Augusto Villanueva; Jean-Charles Nault; Josep M Llovet
Journal:  Gastroenterology       Date:  2015-06-20       Impact factor: 22.682

6.  Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.

Authors:  Dilek Cevik; Gokhan Yildiz; Mehmet Ozturk
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 7.  Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors (Review).

Authors:  Dai Shimizu; Yoshikuni Inokawa; Fuminori Sonohara; Kenichi Inaoka; Shuji Nomoto
Journal:  Oncol Rep       Date:  2017-03-31       Impact factor: 3.906

Review 8.  The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

Authors:  Stephen Caldwell; Sang H Park
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

Review 9.  Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.

Authors:  Jean-Luc Raoul; Joong-Won Park; Yoon-Koo Kang; Richard S Finn; Jun Suk Kim; Winnie Yeo; Blasé N Polite; Yee Chao; Ian Walters; Christine Baudelet; Riccardo Lencioni
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

Review 10.  Tumor markers for hepatocellular carcinoma.

Authors:  Yan-Jie Zhao; Qiang Ju; Guan-Cheng Li
Journal:  Mol Clin Oncol       Date:  2013-05-13
View more
  2 in total

1.  New Insights From Imputed Whole-Genome Sequence-Based Genome-Wide Association Analysis and Transcriptome Analysis: The Genetic Mechanisms Underlying Residual Feed Intake in Chickens.

Authors:  Shaopan Ye; Zi-Tao Chen; Rongrong Zheng; Shuqi Diao; Jinyan Teng; Xiaolong Yuan; Hao Zhang; Zanmou Chen; Xiquan Zhang; Jiaqi Li; Zhe Zhang
Journal:  Front Genet       Date:  2020-04-03       Impact factor: 4.599

2.  Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.

Authors:  Elisabeth Drucker; Kerstin Holzer; Stefan Pusch; Juliane Winkler; Diego F Calvisi; Eva Eiteneuer; Esther Herpel; Benjamin Goeppert; Stephanie Roessler; Alessandro Ori; Peter Schirmacher; Kai Breuhahn; Stephan Singer
Journal:  Cell Commun Signal       Date:  2019-11-29       Impact factor: 5.712

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.